Ausgabe 5/2019
Inhalt (22 Artikel)
The Case for the Use of Patient and Caregiver Perception of Change Assessments in Rare Disease Clinical Trials: A Methodologic Overview
Marielle G. Contesse, James E. Valentine, Tracy E. Wall, Mindy G. Leffler
Reporting Clinical Trial Results of Phytomedicines in Acute Rhinosinusitis: Letter to the Editor Regarding Gottschlich S, Röschmann K, Candler H. Adv Ther (2018); 35:1023–1034. doi: 10.1007/s12325-018-0736-7
Claus Bachert, Mayank Thakur, Simon Weyers, Claudia Bittner, Dimitri Abramov-Sommariva
Response Letter Addressing Letter to the Editor Regarding Gottschlich S, Röschmann K, Candler H. Adv Ther (2018); 35:1023–1034. doi:10.1007/s12325-018-0736-7
Stefan Gottschlich, Kristina Röschmann, Henning Candler
Differentiating Basal Insulin Preparations: Understanding How They Work Explains Why They Are Different
Alice Y. Y. Cheng, Dhiren K. Patel, Timothy S. Reid, Kathleen Wyne
Appropriate Titration of Basal Insulin in Type 2 Diabetes and the Potential Role of the Pharmacist
Dhiren Patel, Curtis Triplitt, Jennifer Trujillo
Pharmacological Treatment for Non-alcoholic Fatty Liver Disease
Sven Francque, Luisa Vonghia
Bloating and Abdominal Distension: Clinical Approach and Management
Amir Mari, Fadi Abu Backer, Mahmud Mahamid, Hana Amara, Dan Carter, Doron Boltin, Ram Dickman
Efficacy of Chondroitin Sulfate in Patients with Knee Osteoarthritis: A Comprehensive Meta-Analysis Exploring Inconsistencies in Randomized, Placebo-Controlled Trials
Germain Honvo, Olivier Bruyère, Anton Geerinck, Nicola Veronese, Jean-Yves Reginster
Economic Burden of Illness Among Commercially Insured Patients with Systemic Sclerosis with Interstitial Lung Disease in the USA: A Claims Data Analysis
Zhou Zhou, Yanni Fan, Darren Thomason, Wenxi Tang, Xinyue Liu, Zheng-Yi Zhou, Dendy Macaulay, Aryeh Fischer
Cost-Effectiveness of Alectinib for Patients with Untreated ALK-Positive Non-Small Cell Lung Cancer in China
Haijing Guan, Yanan Sheng, Wanjie Guo, Sheng Han, Luwen Shi
The Effectiveness, Safety, and Tolerability of Pirfenidone in Idiopathic Pulmonary Fibrosis: A Retrospective Study
Ismail Hanta, Aykut Cilli, Can Sevinc
A Propensity Score Matched Comparison of Brand and Biosimilar Basal Insulin in Non-Critical Hospitalized Patients with Type 2 Diabetes Mellitus
Xia Hu, Lei Zhang, Chao Dong, Yanhu Dong, Jikang Jiang, Weiguo Gao
The Effectiveness of Ankaferd Blood Stopper in the Management of Traumatic Bleeding
Nazmiye Koyuncu
Maximum Tolerated Dose and Pharmacokinetics of Paclitaxel Micellar in Patients with Recurrent Malignant Solid Tumours: A Dose-Escalation Study
Olof Borgå, Roger Henriksson, Helena Bjermo, Elsa Lilienberg, Nina Heldring, Niklas Loman
Survival, Motor Function, and Motor Milestones: Comparison of AVXS-101 Relative to Nusinersen for the Treatment of Infants with Spinal Muscular Atrophy Type 1
Omar Dabbous, Benit Maru, Jeroen P. Jansen, Maria Lorenzi, Martin Cloutier, Annie Guérin, Irina Pivneva, Eric Q. Wu, Ramesh Arjunji, Douglas Feltner, Douglas M. Sproule
Assessing the Role of Anti rh-GAA in Modulating Response to ERT in a Late-Onset Pompe Disease Cohort from the Italian GSDII Study Group
Massimiliano Filosto, Stefano Cotti Piccinelli, Sabrina Ravaglia, Serenella Servidei, Maurizio Moggio, Olimpia Musumeci, Maria Alice Donati, Elena Pegoraro, Antonio Di Muzio, Lorenzo Maggi, Paola Tonin, Gianni Marrosu, Cristina Sancricca, Alberto Lerario, Michele Sacchini, Claudio Semplicini, Virginia Bozzoni, Roberta Telese, Silvia Bonanno, Rachele Piras, Maria Antonietta Maioli, Giulia Ricci, Liliana Vercelli, Anna Galvagni, Serena Gallo Cassarino, Filomena Caria, Tiziana Mongini, Gabriele Siciliano, Alessandro Padovani, Antonio Toscano
A Relative Cost of Control Analysis of Once-Weekly Semaglutide Versus Exenatide Extended-Release and Dulaglutide for Bringing Patients to HbA1c and Weight Loss Treatment Targets in the USA
Pierre Johansen, Barnaby Hunt, Neeraj N. Iyer, Tam Dang-Tan, Richard F. Pollock
Correction to: A Relative Cost of Control Analysis of Once-Weekly Semaglutide Versus Exenatide Extended-Release and Dulaglutide for Bringing Patients to HbA1c and Weight Loss Treatment Targets in the USA
Pierre Johansen, Barnaby Hunt, Neeraj N. Iyer, Tam Dang-Tan, Richard F. Pollock
Switching “Real-World” Diabetes Patients to Degludec from Other Basal Insulins Provides Different Clinical Benefits According to Their Baseline Glycemic Control
Nikolaos Tentolouris, Søren T. Knudsen, Annunziata Lapolla, Michael Lyng Wolden, Steffen Haldrup, Bernd Schultes
Thyroid Cancer Benefits the Prognosis of Ovarian Cancer: A SEER-Based Study
Qiong Yang, Zhiyong Wu, Xujun He, Leibo Yu, Xiaofei Zhang, Kefeng Lei
Long-Term Effects and Adverse Events of Nintedanib Therapy in Idiopathic Pulmonary Fibrosis Patients with Functionally Advanced Disease
Eniko Barczi, Livia Starobinski, Abigel Kolonics-Farkas, Noemi Eszes, Aniko Bohacs, Martina Vasakova, Karel Hejduk, Veronika Müller
Correction to: Safety and Efficacy of Ripasudil in Japanese Patients with Glaucoma or Ocular Hypertension: 3-month Interim Analysis of ROCK-J, a Post-Marketing Surveillance Study
Hidenobu Tanihara, Takahiko Kakuda, Tetsuro Sano, Takashi Kanno, Ryosuke Imada, Wataru Shingaki, Ryoji Gunji